Here are five numbers on private equity that ASC leaders are monitoring:

There have been 443 healthcare sector private equity deals in 2023 — a figure estimated to hit 577 by year's end, according to a report published Nov. 7 by market research firm PitchBook. 

The number of private equity deals in the healthcare sector during the third quarter was down 28% from that of 2023's second quarter, according to a report published Nov. 7 by market research firm PitchBook. 

Four major private equity deals shook up healthcare in the third quarter, according to Provident's third-quarter "Mergers and Acquisitions Update" report.

Here are the private equity groups behind some of the biggest forces in the ASC industry:

Here are five private equity forces driving growth in the ASC industry:

 As the ASC industry continues to grow and inflationary pressures persist, private equity strategy will likely begin to shift, according to a Sept. 29 VMG Health report. 

ASC is attracting private equity investment across the country. VMG Health laid out the reasons why in a Sept. 21 blog post. 

Private equity has an increasing interest in healthcare, particularly cardiology, EHR companies and physician groups:

Private equity has a new investment target: EHR vendors. 

In a recent article in Becker's ASC Review, private equity was listed as one of three disruptors in the ASC Space, the other two being supply costs and staffing shortages. 

As private equity's influence in healthcare increases, many leaders are concerned about how it will affect physicians and ASCs. 

Here are five private equity powerhouses ASC leaders should know: 

Elgin, Ill.-based DxTx Pain and Spine has secured a $50 million private equity investment from international firm BC Partners Credit. 

Orthopedics has a unique position within the healthcare ecosystem as a highly fragmented industry ripe with potential for standardization and value-based care. There is a strong demand for affiliation with orthopedic groups, according to a new report from VMG Health, and more transactions could be on the horizon.

Private equity firms spent $206 billion on 1,400 healthcare acquisitions in 2021, according to a report by AMN Healthcare. 

As private equity becomes more prevalent in healthcare, physicians have divided opinions on its importance and its use. 

Here are five private equity-backed ASC-focused companies making waves in the surgery center space: 

As private equity increasingly invests in ASCs and physician groups, some leaders are concerned about its effect on patient outcomes and costs. 

Here are six notes about private equity's ASC influence from the last year: